<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.0 20040830//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">09-PONE-RA-12078</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0007197</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Biochemistry/Cell Signaling and Trafficking Structures</subject><subject>Cell Biology/Cell Signaling</subject><subject>Cell Biology/Cellular Death and Stress Responses</subject><subject>Gastroenterology and Hepatology/Colon and Rectum</subject><subject>Gastroenterology and Hepatology/Inflammatory Bowel Disease</subject><subject>Cell Biology/Extra-Cellular Matrix</subject></subj-group></article-categories><title-group><article-title>Lipid Alterations in Experimental Murine Colitis: Role of Ceramide and Imipramine for Matrix Metalloproteinase-1 Expression</article-title><alt-title alt-title-type="running-head">Ceramide and Colitis</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bauer</surname><given-names>Jessica</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Liebisch</surname><given-names>Gerhard</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hofmann</surname><given-names>Claudia</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Huy</surname><given-names>Christian</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Schmitz</surname><given-names>Gerd</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Obermeier</surname><given-names>Florian</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bock</surname><given-names>J&#x000fc;rgen</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Internal Medicine I, University Medical Center, Regensburg, Germany</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Institute for Clinical Chemistry, University Medical Center, Regensburg, Germany</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Bereswill</surname><given-names>Stefan</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Charit&#x000e9;-Universit&#x000e4;tsmedizin Berlin, Germany</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>juergen.bock@klinik.uni-regensburg.de</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: JB JB. Performed the experiments: JB GL CH CH. Analyzed the data: JB JB. Contributed reagents/materials/analysis tools: GL GS FO. Wrote the paper: JB JB.</p></fn></author-notes><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>29</day><month>9</month><year>2009</year></pub-date><volume>4</volume><issue>9</issue><elocation-id>e7197</elocation-id><history><date date-type="received"><day>5</day><month>8</month><year>2009</year></date><date date-type="accepted"><day>25</day><month>8</month><year>2009</year></date></history><permissions><copyright-statement>Bauer et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement></permissions><abstract><sec><title>Background</title><p>Dietary lipids or pharmacologic modulation of lipid metabolism are potential therapeutic strategies in inflammatory bowel disease (IBD). Therefore, we analysed alterations of bioactive lipids in experimental models of colitis and examined the functional consequence of the second messenger ceramide in inflammatory pathways leading to tissue destruction.</p></sec><sec><title>Methodology/Principal Findings</title><p>Chronic colitis was induced by dextran-sulphate-sodium (DSS) or transfer of CD4<sup>&#x0002b;</sup>CD62L<sup>&#x0002b;</sup> cells into RAG1<sup>&#x02212;/&#x02212;</sup>-mice. Lipid content of isolated murine intestinal epithelial cells (IEC) was analysed by tandem mass spectrometry. Concentrations of MMP-1 in supernatants of Caco-2-IEC and human intestinal fibroblasts from patients with ulcerative colitis were determined by ELISA. Imipramine was used for pharmacologic inhibition of acid sphingomyelinase (ASM). Ceramide increased by 71&#x00025; in chronic DSS&#x02013;induced colitis and by 159&#x00025; in the transfer model of colitis. Lysophosphatidylcholine (LPC) decreased by 22&#x00025; in both models. No changes were detected for phosphatidylcholine. Generation of ceramide by exogenous SMase increased MMP-1-protein production of Caco-2-IEC up to 7-fold. Inhibition of ASM completely abolished the induction of MMP-1 by TNF or IL-1&#x003b2; in Caco-2-IEC and human intestinal fibroblasts.</p></sec><sec><title>Conclusions/Significance</title><p>Mucosal inflammation leads to accumulation of ceramide and decrease of LPC in the intestinal epithelium. One aspect of ceramide generation is an increase of MMP-1. Induction of MMP-1 by TNF or IL-1&#x003b2; is completely blocked by inhibition of ASM with imipramine. Therefore, inhibition of ASM may offer a treatment strategy to reduce MMP-1 expression and tissue destruction in inflammatory conditions.</p></sec></abstract><counts><page-count count="8"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Many signalling molecules involved in the pathogenesis of inflammatory bowel disease (IBD) such as tumor necrosis factor (TNF) or interleukin-1 beta (IL-1&#x003b2;) cause alterations of the lipid composition in the cell membrane by activation of various phospholipases, sphingomyelinases and other lipid modifying enzymes <xref ref-type="bibr" rid="pone.0007197-Schtze1">&#x0005b;1&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0007197-Wymann1">&#x0005b;4&#x0005d;</xref>. Previous reports demonstrated therapeutic effects of lipid administration <xref ref-type="bibr" rid="pone.0007197-Fabia1">&#x0005b;5&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0007197-Stremmel1">&#x0005b;7&#x0005d;</xref> or inhibition of lipid modifying enzymes <xref ref-type="bibr" rid="pone.0007197-Sakata1">&#x0005b;8&#x0005d;</xref> for the treatment of intestinal inflammation. Ceramide or lysophosphatidylcholine play key roles as second messengers for intracellular signalling with the potential to control inflammatory responses.</p><p>Ceramide is generated by de novo synthesis or hydrolysis of plasma membrane sphingomyelin via the action of sphingomyelinases (SMases). SMases are characterized by their optimal pH and are divided accordingly into acid, neutral and basic sphingomyelinase species. The acid sphingomyelinase (ASM) contributes to lysosomal sphingomyelin turnover and is also secreted upon cellular treatment with inflammatory stimuli <xref ref-type="bibr" rid="pone.0007197-Smith1">&#x0005b;9&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007197-Gulbins1">&#x0005b;10&#x0005d;</xref>. Ceramide has been implicated in a variety of cellular processes from cell growth, differentiation and gene transcription to cell death <xref ref-type="bibr" rid="pone.0007197-Ballou1">&#x0005b;11&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007197-Kolesnick1">&#x0005b;12&#x0005d;</xref>. Ceramide seems to play a central role for the pathophysiology of several common diseases <xref ref-type="bibr" rid="pone.0007197-Smith1">&#x0005b;9&#x0005d;</xref> and is a key mediator for apoptosis, cellular invasion of bacteria and viruses, radiation- and chemotherapeutic responses, heat damage, UVA-light and ischemia-reperfusion injury <xref ref-type="bibr" rid="pone.0007197-Gulbins2">&#x0005b;13&#x0005d;</xref>. Increasing evidence suggests implications of SMases in the development of colon cancer or IBD <xref ref-type="bibr" rid="pone.0007197-Gulbins2">&#x0005b;13&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007197-Duan1">&#x0005b;14&#x0005d;</xref>. Inhibition of ASM has been shown to protect from DSS-induced colitis in mice <xref ref-type="bibr" rid="pone.0007197-Sakata2">&#x0005b;15&#x0005d;</xref>. The authors suggested that the protective effect of ASM-inhibition was mediated by the suppression of cytokine production from macrophages in response to LPS. Unfortunately, the response of intestinal epithelial cells (IEC) and fibroblasts has not been investigated, although these cells may well contribute to the protective effects of ASM-inhibition.</p><p>Phosphatidylcholine (PC) is the main phospholipid component of eukaryotic cells. Instillation of PC and phosphatidylinositol have been shown to prevent acetic acid-induced colitis in the rat <xref ref-type="bibr" rid="pone.0007197-Fabia1">&#x0005b;5&#x0005d;</xref>. The formation of strictures in a rat model of colitis was also prevented by oral supplementation of polyunsaturated PC, possibly by stimulation of collagen breakdown <xref ref-type="bibr" rid="pone.0007197-Mourelle1">&#x0005b;6&#x0005d;</xref>. The studies by Stremmel et al focused on the content of PC in mucus layers as the possible culprit for uncontrolled inflammation of the intestine <xref ref-type="bibr" rid="pone.0007197-Stremmel1">&#x0005b;7&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007197-Ehehalt1">&#x0005b;16&#x0005d;</xref> which may be prevented by administration of PC. Nevertheless, in vitro studies revealed that exogenously added PC is also integrated into the cells and has anti-inflammatory properties in Caco-2 intestinal epithelial cells, especially in response to TNF <xref ref-type="bibr" rid="pone.0007197-Treede1">&#x0005b;17&#x0005d;</xref>. Lysophosphatidylcholine (LPC) is a metabolic product of PC and displays inflammatory activity. Biosynthesis is regulated by PLA<sub>2</sub> that catalyzes PC hydrolysis <xref ref-type="bibr" rid="pone.0007197-McKean1">&#x0005b;18&#x0005d;</xref>. LPC acts as a chemotactic factor for monocytes and T cells and displays proinflammatory properties even at nanomolar concentrations <xref ref-type="bibr" rid="pone.0007197-Olofsson1">&#x0005b;19&#x0005d;</xref>. Phosphatidylethanolamine (PE) and plasmalogenes (PE-pl) serve as precursors for lipoxygenases, thereby contributing to immune-regulatory activities <xref ref-type="bibr" rid="pone.0007197-Maskrey1">&#x0005b;20&#x0005d;</xref>.</p><p>Excessively produced Matrix Metalloproteinase-1 (MMP-1) is believed to damage the colonic mucosa in patients with ulcerative colitis <xref ref-type="bibr" rid="pone.0007197-Wang1">&#x0005b;21&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007197-Meijer1">&#x0005b;22&#x0005d;</xref>. MMP-1, also called interstitial collagenase, belongs to a family of zinc-dependent metalloendopeptidases collectively capable of degrading essentially all extracellular matrix (ECM) components <xref ref-type="bibr" rid="pone.0007197-Westermarck1">&#x0005b;23&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007197-Sengupta1">&#x0005b;24&#x0005d;</xref>. Most of the MMPs are secreted as proenzymes and require proteolytic cleavage for activation <xref ref-type="bibr" rid="pone.0007197-Naito1">&#x0005b;25&#x0005d;</xref>. Activity of MMPs is further regulated by a group of endogenous proteins, so called tissue inhibitors of metalloproteinases (TIMPs) that bind to active and alternative sites of activated MMPs <xref ref-type="bibr" rid="pone.0007197-WojtowiczPraga1">&#x0005b;26&#x0005d;</xref>. The balance of activated MMPs and TIMPs is crucial to maintain tissue allostasis. Excessive production or activation of MMPs results in uncontrolled degradation of ECM <xref ref-type="bibr" rid="pone.0007197-Naito1">&#x0005b;25&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007197-Baugh1">&#x0005b;27&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007197-Heuschkel1">&#x0005b;28&#x0005d;</xref>. MMP-1 is increased upon stimulation with inflammatory cytokines such as IL-1&#x003b2; or TNF <xref ref-type="bibr" rid="pone.0007197-Mackay1">&#x0005b;29&#x0005d;</xref>, ionizing radiation <xref ref-type="bibr" rid="pone.0007197-Lafuma1">&#x0005b;30&#x0005d;</xref> or UVA irradiation <xref ref-type="bibr" rid="pone.0007197-Wlaschek1">&#x0005b;31&#x0005d;</xref>. Expression of MMP-1 has been linked with ceramide metabolism via activation of extracellular signal-regulated and stress-activated protein kinase pathways <xref ref-type="bibr" rid="pone.0007197-Reunanen1">&#x0005b;32&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007197-Bu1">&#x0005b;33&#x0005d;</xref> but the relevance of this association for the mentioned stimuli and the involvement of endogenous SMases remain to be determined. ASM-activating cytokines and stimuli greatly overlap with the stimulatory processes which increase MMP-1. Therefore, we investigated the effects of these stimuli on MMP-1 production in IEC and intestinal fibroblasts.</p><p>To determine the occurring lipid alterations in intestinal inflammation, we quantified bioactive lipids in two murine models of chronic colitis. The increase of ceramide was linked with the secretion of MMP-1. Exogenous SMase produced high levels of MMP-1 in Caco-2 IEC and induction of MMP-1 by TNF or IL-1&#x003b2; was completely abrogated by inhibition of ASM with imipramine.</p></sec><sec sec-type="materials|methods" id="s2"><title>Materials and Methods</title><sec id="s2a"><title>Mice</title><p>Female Balb/c (Harlan Winkelmann, Borchen, Germany) and RAG1<sup>&#x02212;/&#x02212;</sup> mice (Taconic, USA) weighing 19&#x02013;22 g were individually housed in standard polycarbonate mouse cages for at least two weeks before the start of the experiment. All mice were kept under standard laboratory conditions (12-h light/dark cycle, 22&#x000b1;2&#x000b0;C; 60&#x000b1;5&#x00025; humidity). All experimental protocols were approved by the Committee on Animal Health and Care of the local government (AZ 621-2531.1-08/04), and conformed to international guidelines on the ethical use of animals. All efforts were made to minimize the number of animals used and their suffering.</p></sec><sec id="s2b"><title>Cells and reagents</title><p>Caco-2 cells were maintained in Dulbecco's minimum essential medium (DMEM), supplemented with 10&#x00025; fetal calf serum (FCS), 1&#x00025; penicillin/streptomycin, 1&#x00025; non-essential amino acids and 1&#x00025; sodium pyruvate in an atmosphere containing 10&#x00025; CO<sub>2</sub> at 37&#x000b0;C. FCS was inactivated for 1h, 50&#x000b0;C. Isolation and cultivation of fibroblasts is described below. For quantification of MMP-1 protein by ELISA, experiments were performed without FCS. To avoid prestimulation by serum withdrawal, primary fibroblasts were maintained in medium with 0.5&#x00025; FCS prior to stimulation with TNF. Sphingomyelinase from staphylococcus aureus and imipramine were purchased from Sigma-Aldrich, Taufkirchen, Germany. IL-1&#x003b2;, TNF and MMP-1 ELISA were purchased from R&#x00026;D Systems, Wiesbaden, Germany.</p></sec><sec id="s2c"><title>Isolation of human fibroblasts from patients</title><p>Human fibroblasts were isolated from colonic sections of patients with ulcerative colitis or sections of non-IBD patients without inflammation. Fibroblasts were isolated and cultured as previously described <xref ref-type="bibr" rid="pone.0007197-Leeb1">&#x0005b;34&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007197-Brenmoehl1">&#x0005b;35&#x0005d;</xref>. In brief, the mucosa from surgical patients was cut into 1-mm pieces and epithelial cells were removed in Hank's Balanced Salt Solution (HBSS) without Ca<sup>2&#x0002b;</sup> and Mg<sup>2&#x0002b;</sup> (PAA, C&#x000f6;lbe, Germany) with 2mM ethylenediaminetetraacetic acid (EDTA) (Sigma-Aldrich, Taufkirchen, Germany). The remaining tissue was digested for 30 min at 37&#x000b0;C in phosphate-buffered saline (PBS, Gibco, Karlsruhe, Germany) containing 1 mg/ml collagenase I (Sigma-Aldrich), 0.3mg/ml DNase I (Roche, Mannheim, Germany), and 2mg/ml hyaluronidase (Sigma-Aldrich). Isolated cells were washed with DMEM containing 20&#x00025; FCS and cultured in 25-cm<sup>2</sup> culture flasks (Costar, Bodenheim, Germany) with DMEM containing 10&#x00025; FCS, penicillin (100IU/ml), streptomycin (100 &#x000b5;g/ml), ciprofloxacin (8 &#x000b5;g/ml), gentamycin (50 &#x000b5;g/ml), and amphotericin B (1 &#x000b5;g/ml). Non-adherent cells were removed by subsequent changes of medium.</p></sec><sec id="s2d"><title>Antibodies</title><p>The following antibodies were used for flow cytometry (FACS) analysis: Rat anti-mouse G8.8 (Ep-CAM) antibody was a kind gift by Dr. U. Strauch, Regensburg, Germany. Fluorescein (FITC) conjugated F(ab')2 fragment goat anti-rat IgG were from Jackson ImmunoResearch, Suffolk, UK.</p></sec><sec id="s2e"><title>MMP-1 ELISA</title><p>For detection of MMP-1, fibroblasts and Caco-2 cells were seeded in 12-well plates. Experiments were performed in medium without FCS or 0.5&#x00025; FCS in the case of stimulation by TNF. Cells were incubated with the indicated substances. For pharmacologic inhibition of ASM imipramine (30 &#x000b5;M) was used. Concentration of MMP-1 in supernatants was determined by ELISA (R&#x00026;D Systems). All measurements were performed in duplicate.</p></sec><sec id="s2f"><title>Dextran sulphate sodium (DSS) induced chronic colitis</title><p>For induction of chronic colitis mice received 3&#x00025; DSS (MP Biomedicals, Illkirch, France) in drinking water for 7 days, as described previously <xref ref-type="bibr" rid="pone.0007197-Obermeier1">&#x0005b;36&#x0005d;</xref>. Each cycle consisted of 3&#x00025; DSS in drinking water for 7 days, followed by a 7 days interval with normal drinking water. Mice were failed to 4 cycles and were used for the experimental treatment 4 weeks after completion of the last cycle.</p></sec><sec id="s2g"><title>CD4<sup>&#x0002b;</sup>CD62L<sup>&#x0002b;</sup> T cell transfer model of colitis</title><p>Splenic CD4<sup>&#x0002b;</sup>CD62L<sup>&#x0002b;</sup> T cells from Balb/c mice were isolated as described previously <xref ref-type="bibr" rid="pone.0007197-Neurath1">&#x0005b;37&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007197-Mudter1">&#x0005b;38&#x0005d;</xref>. In brief, CD4<sup>&#x0002b;</sup>CD62L<sup>&#x0002b;</sup> T cells were purified from spleen mononuclear cells of healthy mice by CD4<sup>&#x0002b;</sup>CD62L<sup>&#x0002b;</sup> T Cell isolation kit with immunomagnetic microbeads (Miltenyi Biotech, Bergisch Gladbach, Germany). CD4<sup>&#x0002b;</sup>CD62L<sup>&#x0002b;</sup> T cells (0.25&#x000d7;10<sup>6</sup>) were resuspended in 200 &#x000b5;l of sterile phosphate buffered saline (PBS) and injected intraperitoneally in recipient RAG1<sup>&#x02212;/&#x02212;</sup> deficient mice. Colitis activity was monitored by weight changes and histological analysis. After 6&#x02013;8 weeks mice were used for experiments.</p></sec><sec id="s2h"><title>Histological score</title><p>For the histological analyses cross sections of the colon were fixed in 4&#x00025; formalin and the tissue was embedded in paraffin, sliced in sections of 2 &#x000b5;m thickness and stained with haematoxylin-eosin and scored as described <xref ref-type="bibr" rid="pone.0007197-Obermeier1">&#x0005b;36&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007197-Steidler1">&#x0005b;39&#x0005d;</xref>. The predominant feature of microscopic inflammation in colitis is the mononuclear cell infiltration limited to the mucosa and the consecutive mucosal damage with loss of goblet cells and loss of crypts. Both features were independently graded from 0 to 4 and the mean score was noted. The total histological score represents the sum of the epithelium and infiltration score and ranges from 0 to 8.</p></sec><sec id="s2i"><title>Affymetrix gene array</title><p>First, Caco-2 cells (6&#x000d7;75cm<sup>2</sup> flask) were stimulated with exogenous SMase (0.1 U/ml) for 6h and 24h. After incubation, cells were isolated with RNeasy Mini Kit (Qiagen, Hilden, Germany). Gene expression profiles were determined as described before <xref ref-type="bibr" rid="pone.0007197-Langmann1">&#x0005b;40&#x0005d;</xref> using Affymetrix HGU133A and HGU133B GeneChips (Affymetrix, Santa Clara, CA), which cover 22,283 annotated human genes (U133A) and more than 33,000 human EST sequences (U133B). Caco-2 RNA stimulated with exogenous SMase (6h and 24h) was used for pooling to generate complementary RNA (cRNA). The remaining amount of RNA was used for real-time RT-PCR validation in single samples. 10 &#x000b5;g of pooled total RNA was converted to complementary DNA (cDNA) using a T7-oligo-d(T)<sub>24</sub> primer and SuperScript reverse transcriptase (Invitrogen, Carlsbad, CA, USA). Second-strand cDNA synthesis and blunt ending was performed using T4 DNA polymerase, <italic>Escherichia coli</italic> DNA ligase, and T4 polynucleotide kinase. Following phenol-chloroform extraction, cDNA was used for in vitro transcription reaction using the T7 BioArray High Yield RNA Transcript Labeling Kit (Enzo Diagnostics, Farmingdale, NY, USA) to produce biotinylated cRNA. Thereafter, the labeled cRNA was purified using RNeasy Mini Kit columns (Qiagen) and fragmented by incubation at 94&#x000b0;C for 30 minutes. Fragmentation was checked by microcapillary electrophoresis on an Agilent 2100 bioanalyzer, and 30 &#x000b5;g of biotinylated cRNAs was split into 2 parts and hybridized to U133A and U133B GeneChips, respectively, for 16 hours at 45&#x000b0;C with constant rotation. Microarray was processed in an Affymetrix GeneChip Fluidics Station 400. Following staining with streptavidin-conjugated phycoerythrin and washing cycles, the microarrays were scanned using the GeneArray Scanner (Agilent Technologies). Expression signals for each transcript and comparisons between different samples were calculated with the Affymetrix GeneChip software MAS5.0 and Microsoft Excel (Microsoft Corp., Redmond, WA) <xref ref-type="bibr" rid="pone.0007197-Langmann1">&#x0005b;40&#x0005d;</xref>.</p></sec><sec id="s2j"><title>Tandem mass spectrometry</title><p>Intestinal epithelial cells (IECs) were isolated from mice colon as previous described <xref ref-type="bibr" rid="pone.0007197-Daig1">&#x0005b;41&#x0005d;</xref>. After isolation, cells were washed with ice-cold PBS twice. Samples were prepared by addition of 500 &#x000b5;l ice-cold H<sub>2</sub>O with 0.2&#x00025; SDS, followed by addition of 500 &#x000b5;l H<sub>2</sub>O. Lipids were quantified by electrospray ionization tandem mass spectrometry (ESI-MS/MS) in positive ion mode as described previously <xref ref-type="bibr" rid="pone.0007197-Liebisch1">&#x0005b;42&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007197-Wiesener1">&#x0005b;43&#x0005d;</xref>. Samples were quantified by direct flow injection analysis using the analytical setup and the data analysis algorithms described by Liebisch et al. <xref ref-type="bibr" rid="pone.0007197-Liebisch1">&#x0005b;42&#x0005d;</xref>. A parent ion scan of <italic>m/z</italic> 184 specific for phosphocholine containing lipids was used for phosphatidylcholine, sphingomyelin and lysophosphatidylcholine. Neutral loss scans of <italic>m/z</italic> 141 and <italic>m/z</italic> 185 were used for phosphatidylethanolamine and phosphatidylserine, respectively. PE-based plasmalogens (PE-pl) were analysed by fragment ions of <italic>m/z</italic> 364, 380 and 382 for PE p16&#x02236;0, p18&#x02236;1 and p18&#x02236;0 species, respectively. Ceramide was analysed using N-heptadecanoyl-sphingosine as internal standard. Free cholesterol (FC) and CE species were determined after selective acetylation of FC. Quantification was achieved by calibration lines generated by addition of naturally occurring lipid species to cell homogenates.</p></sec><sec id="s2k"><title>Statistical analysis</title><p>Data are shown using vertical Box-Whisker plots (25&#x00025; and 75&#x00025; values), generated in the basic module of the programs SigmaPlot/SigmaStat. Statistical analysis was performed by student's t-test or Mann-Whitney U-test, with p&#x0003c;0.05 considered statistically significant. Data are given as means &#x000b1; SEM.</p></sec></sec><sec id="s3"><title>Results</title><sec id="s3a"><title>Lipid alterations in chronic DSS&#x02013;induced colitis and CD4<sup>&#x0002b;</sup>CD62L<sup>&#x0002b;</sup> transfer model of colitis: increase of ceramide, decrease of lysophosphatidylcholine</title><p>To identify inflammation induced lipid alterations, we first analysed the occurring changes of bioactive lipids in experimental models of chronic colitis by tandem mass spectrometry.</p><p>Isolated colonic IEC of mice suffering from chronic DSS-induced colitis showed the following lipid alterations when compared to control (<xref ref-type="fig" rid="pone-0007197-g001">Figure 1A&#x02013;1C</xref>):</p><fig id="pone-0007197-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007197.g001</object-id><label>Figure 1</label><caption><title>Increase of ceramide and decrease of LPC in chronic DSS-induced colitis.</title><p>(A&#x02013;C) Lipid analysis of isolated colonic IEC by tandem mass spectrometry (control n&#x0200a;&#x0003d;&#x0200a;12, 3&#x00025; DSS n&#x0200a;&#x0003d;&#x0200a;10). (A) Proportion of ceramide and LPC of analysed lipids. (B) Proportion of PC and FC of analysed lipids. (C) Proportion of SM, PE and PE-pl of analysed lipids. (D) Histological score. (E) Surface expression of epithelial cell marker, determined by flow cytometry after staining of the cells with FITC-labelled anti G8.8 antibodies. (&#x0002a;&#x0002a;p&#x0003c;0.01, &#x0002a;&#x0002a;&#x0002a;p&#x0003c;0.001)</p></caption><graphic xlink:href="pone.0007197.g001"/></fig><p>Ceramide increased by 71&#x00025; (<xref ref-type="fig" rid="pone-0007197-g001">Figure 1A</xref>). In contrast, lysophosphatidylcholine (LPC) decreased by 22&#x00025; (<xref ref-type="fig" rid="pone-0007197-g001">Figure 1A</xref>). Levels of phosphatidylcholine remained constant (<xref ref-type="fig" rid="pone-0007197-g001">Figure 1B</xref>). Free cholesterol (<xref ref-type="fig" rid="pone-0007197-g001">Figure 1B</xref>), Sphingomyelin (<xref ref-type="fig" rid="pone-0007197-g001">Figure 1C</xref>) and phosphatidyl-ethanolamine (<xref ref-type="fig" rid="pone-0007197-g001">Figure 1C</xref>) declined. Plasmalogenes (<xref ref-type="fig" rid="pone-0007197-g001">Figure 1C</xref>) increased. Histological score of mice with DSS-induced colitis versus control is shown in <xref ref-type="fig" rid="pone-0007197-g001">Figure 1D</xref>. To exclude contamination of IEC by other cells, isolated cells were stained with FITC-coupled anti-G8.8 antibodies, specific for epithelial cells <xref ref-type="bibr" rid="pone.0007197-Farr1">&#x0005b;44&#x0005d;</xref>. Flow cytometry revealed that more than 93&#x00025; of isolated cells were of epithelial origin (<xref ref-type="fig" rid="pone-0007197-g001">Figure 1E</xref>), indicating a good purification of IEC without relevant numbers of other mucosal cells.</p><p>Colonic IEC from mice with chronic colitis by transfer of CD4<sup>&#x0002b;</sup>CD62L<sup>&#x0002b;</sup> cells displayed the following changes (<xref ref-type="fig" rid="pone-0007197-g002">Figure 2A and 2B</xref>):</p><fig id="pone-0007197-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007197.g002</object-id><label>Figure 2</label><caption><title>Increase of ceramide and decrease of LPC in chronic colitis by transfer of CD4<sup>&#x0002b;</sup>CD62L<sup>&#x0002b;</sup> cells in RAG-1<sup>&#x02212;/&#x02212;</sup> mice.</title><p>(A,B) Lipid analysis of isolated colonic IEC by tandem mass spectrometry (control n&#x0200a;&#x0003d;&#x0200a;3, CD4<sup>&#x0002b;</sup>CD62L<sup>&#x0002b;</sup> n&#x0200a;&#x0003d;&#x0200a;6). (A) Proportion of ceramide and LPC of analysed lipids. (B) Proportion of PC and FC of analysed lipids. (C) Histological score. (&#x0002a;p&#x0003c;0.05)</p></caption><graphic xlink:href="pone.0007197.g002"/></fig><p>Ceramide increased by 159&#x00025; (<xref ref-type="fig" rid="pone-0007197-g002">Figure 2A</xref>). In contrast, lysophosphatidylcholine (LPC) decreased by 22&#x00025; (<xref ref-type="fig" rid="pone-0007197-g002">Figure 2A</xref>). Levels of phosphatidylcholine (<xref ref-type="fig" rid="pone-0007197-g002">Figure 2B</xref>) and free cholesterol (<xref ref-type="fig" rid="pone-0007197-g002">Figure 2B</xref>) remained constant. Histological score of mice in CD4<sup>&#x0002b;</sup>CD62L<sup>&#x0002b;</sup> transfer model of colitis was higher compared to control mice (<xref ref-type="fig" rid="pone-0007197-g002">Figure 2C</xref>).</p></sec><sec id="s3b"><title>Increased expression of MMP-1- and MMP-10-mRNA by exogenous SMase in Caco-2 intestinal epithelial cells (IEC)</title><p>Based on the differences found in chronic colitis, we examined the effects of ceramide generation in IEC by affymetrix gene array analysis. Therefore the colorectal cancer cell line Caco-2 was incubated with exogenous SMase (0.1 U/ml) to identify ceramide induced effects possibly involved in IBD pathophysiology. The experiments revealed a fast and robust increase of MMP-1 and MMP-10 (<xref ref-type="fig" rid="pone-0007197-g003">Figure 3</xref>). The induction of MMP-10 was not further investigated.</p><fig id="pone-0007197-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007197.g003</object-id><label>Figure 3</label><caption><title>Induction of MMP-1- and MMP-10-mRNA in the intestinal epithelial cell line Caco-2 after generation of ceramide by exogenous SMase (0,1U/ml), as determined by affymetrix gene array analysis.</title><p>Data are presented as relative increase after 6h and 24h in comparison to untreated control. (n&#x0200a;&#x0003d;&#x0200a;4; &#x0002a;&#x0002a;&#x0002a;p&#x0003c;0.001)</p></caption><graphic xlink:href="pone.0007197.g003"/></fig></sec><sec id="s3c"><title>Exogenous Sphingomyelinase increases MMP-1 protein production in Caco-2 cells</title><p>MMP-1 protein production upon generation of ceramide was confirmed by quantification of active MMP-1 by ELISA. Supernatants of Caco-2 cells were analysed 24h after incubation with exogenous SMase (<xref ref-type="fig" rid="pone-0007197-g004">Figure 4</xref>). Exogenous SMase led to a dose-dependent increase of MMP-1 with a 3.1-fold increase at concentrations as low as 0.005 U/ml and maximal increase at a concentration of 0.125 U/ml (<xref ref-type="fig" rid="pone-0007197-g004">Figure 4</xref>).</p><fig id="pone-0007197-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007197.g004</object-id><label>Figure 4</label><caption><title>MMP-1 protein expression of Caco-2 IEC is induced by exogenous SMase.</title><p>Cells were incubated with increasing doses of exogenous SMase. Concentration of active MMP-1 was determined in supernatants after 24h by ELISA. (&#x0002a;p&#x0003c;0.05, &#x0002a;&#x0002a;p&#x0003c;0.01; n&#x0200a;&#x0003d;&#x0200a;6)</p></caption><graphic xlink:href="pone.0007197.g004"/></fig></sec><sec id="s3d"><title>Inhibition of acid sphingomyelinase (ASM) by imipramine completely abrogates the induction of MMP-1 by IL-1&#x003b2;and TNF</title><p>MMP-1 production in Caco-2 cells was induced by stimulation of cells with the ASM-activating inflammatory cytokines TNF (10ng/ml) or IL-1&#x003b2; (1ng/ml). For inhibition of acid sphingomyelinase, cells were incubated with imipramine (30 &#x000b5;M). Imipramine causes proteolytic degradation of ASM <xref ref-type="bibr" rid="pone.0007197-Albouz1">&#x0005b;45&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0007197-Jensen1">&#x0005b;47&#x0005d;</xref> and was therefore added to the cells 30 minutes prior to stimulation. IL-1&#x003b2; induced a 2.9-fold (&#x000b1;0.07) secretion of MMP-1 (<xref ref-type="fig" rid="pone-0007197-g005">Figure 5A</xref>) which was completely absent in cells treated with imipramine (<xref ref-type="fig" rid="pone-0007197-g005">Figure 5A</xref>). MMP-1 increased by 2.5-fold (&#x000b1;0.1) after stimulation with TNF (<xref ref-type="fig" rid="pone-0007197-g005">Figure 5A</xref>) while treatment of the cells with imipramine completely blocked this increase (<xref ref-type="fig" rid="pone-0007197-g005">Figure 5A</xref>). These results demonstrate ASM-dependence of IL-1&#x003b2; and TNF for MMP-1 induction in the colon epithelial cell line.</p><fig id="pone-0007197-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007197.g005</object-id><label>Figure 5</label><caption><title>Pharmacological inhibition of ASM by imipramine abrogates induction of MMP-1 by IL-1&#x003b2; and TNF.</title><p>Concentration of MMP-1 in supernatants was determined after 24h by ELISA. (A) Stimulation of Caco-2 IEC with IL-1&#x003b2; or TNF &#x000b1; imipramine (n&#x0200a;&#x0003d;&#x0200a;5). (B) Stimulation of primary control fibroblasts CO I (n&#x0200a;&#x0003d;&#x0200a;12), CO II (n&#x0200a;&#x0003d;&#x0200a;9) and CO III (n&#x0200a;&#x0003d;&#x0200a;10) with IL-1&#x003b2; or TNF &#x000b1; imipramine. (C) Stimulation of primary fibroblasts from patients with ulcerative colitis UC I (n&#x0200a;&#x0003d;&#x0200a;10), UC II (n&#x0200a;&#x0003d;&#x0200a;6) and UC III (n&#x0200a;&#x0003d;&#x0200a;6) with IL-1&#x003b2; or TNF &#x000b1; imipramine. (&#x0002a;p&#x0003c;0.05, &#x0002a;&#x0002a;p&#x0003c;0.01; &#x0002a;&#x0002a;&#x0002a;p&#x0003c;0.001)</p></caption><graphic xlink:href="pone.0007197.g005"/></fig><p>Because fibroblasts essentially contribute to MMP-1 production in IBD, we assessed the occurring changes of MMP-1 in primary intestinal fibroblasts upon stimulation with the ASM-activating inflammatory cytokines TNF and IL-1&#x003b2;. Again, we used imipramine for pharmacologic inhibition of ASM, to analyze the contribution of ASM for production of MMP-1. Induction of MMP-1 by IL-1&#x003b2; or TNF was completely abolished by imipramine in all the investigated primary fibroblasts, including three different sets from healthy control (CO I, CO II, CO III) and three sets from patients with ulcerative colitis (UC I, UC II, UC III) (<xref ref-type="fig" rid="pone-0007197-g005">Figure 5B and 5C</xref>). Upon stimulation with IL-1&#x003b2; (1ng/ml) or TNF (10ng/ml), control fibroblasts increased MMP-1 secretion (<xref ref-type="fig" rid="pone-0007197-g005">Figure 5B</xref>). Treatment with imipramine abrogated the effect of IL-1&#x003b2; or TNF with significant inhibition when compared to cells with IL-1&#x003b2; or TNF only. Fibroblasts from patients with ulcerative colitis also increased MMP-1 while treatment with imipramine resulted in MMP-1-levels with significant inhibition when compared to cells with IL-1&#x003b2; or TNF only (<xref ref-type="fig" rid="pone-0007197-g005">Figure 5C</xref>).</p><p>It is important to note that complete serum withdrawal prestimulated the primary fibroblasts with only little response to TNF. Therefore 0.5&#x00025; FCS was maintained to avoid prestimulation of primary fibroblasts by serum withdrawal.</p></sec></sec><sec id="s4"><title>Discussion</title><p>In the present study, we analysed the levels of bioactive lipids in two models of chronic colitis and identified ceramide as a novel second messenger for disease pathology in IBD. We demonstrate that generation of ceramide and activity of acid sphingomyelinase are required for the production of MMP-1, which is believed to damage the colonic mucosa in patients with ulcerative colitis <xref ref-type="bibr" rid="pone.0007197-Wang1">&#x0005b;21&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007197-Meijer1">&#x0005b;22&#x0005d;</xref>.</p><p>Using electrospray ionization tandem mass spectrometry (ESI-MS/MS), we found increased concentrations of ceramide in ex vivo preparations of murine intestinal epithelial cells, and decrease of the degradation product of PC lysophosphatidylcholine. Increased levels of ceramide result from upregulated sphingomyelin breakdown by sphingomyelinases and/or reduced degradation of ceramide by acid ceramidase. To determine the role of the second messenger ceramide, generated by sphingomyelin breakdown, the intestinal epithelial cell line Caco-2 and primary intestinal fibroblasts from patients with ulcerative colitis or healthy controls were challenged with exogenous SMase or the inflammatory cytokines IL-1&#x003b2; and TNF to induce ceramide generation. Affymetrix gene array analysis of Caco-2 IEC revealed dramatic increases of MMP-1 and MMP-10 after generation of ceramide by exogenous SMase. Dose dependent induction of MMP-1 protein expression in Caco-2 IEC upon incubation with exogenous SMase was verified by ELISA. To our knowledge, this is the first description of MMP-1 induction by ceramide in epithelial cells with possible implications for the understanding and treatment of tumor invasion and metastasis. After all, fibroblasts need an inflammatory stimulus in addition to exogenous SMase to induce MMP-1 expression. This regulation is lost in the epithelial cancer cell line Caco-2 which responds with MMP-1 production after generation of ceramide by exogenous SMase alone.</p><p>Using acid sphingomyelinase (ASM)-deficient fibroblasts as a genetic model, we have previously shown ASM-dependent induction of MMP-1 by IL-1&#x003b2; <xref ref-type="bibr" rid="pone.0007197-Bauer1">&#x0005b;48&#x0005d;</xref>. To elucidate the role of sphingomyelin degradation by ASM for MMP-1-induction in IEC and intestinal fibroblasts, activation of ASM was pharmacologically inhibited by imipramine. Imipramine interferes with ceramide signalling, particularly by inhibition of ASM <xref ref-type="bibr" rid="pone.0007197-Albouz1">&#x0005b;45&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0007197-Jensen1">&#x0005b;47&#x0005d;</xref>. TNF and IL-1&#x003b2;, which are known to induce MMP-1 expression as well as to activate ASM, served to evaluate the relevance of ASM-mediated MMP-1-induction <xref ref-type="bibr" rid="pone.0007197-Schtze2">&#x0005b;49&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007197-Hofmeister1">&#x0005b;50&#x0005d;</xref>. Importantly, inhibition of ASM by imipramine completely abrogated the induction of MMP-1 after stimulation with TNF or IL-1&#x003b2;. These data suggest that generation of ceramide by ASM upon TNF or IL-1&#x003b2; augments intestinal tissue destruction by increase of MMP-1 production which can be prevented by inhibition of ASM. Unfortunately, rodents do not express MMP-1. Therefore, we were not able to explore the effects of ASM-inhibition on MMP-1 expression in our murine models of colitis.</p><p>Another consequence of ceramide accumulation may be an increase of cell death and susceptibility to infection, which was demonstrated in a very recent publication by Teichgr&#x000e4;ber et al, employing an animal model of cystic fibrosis <xref ref-type="bibr" rid="pone.0007197-Teichgrber1">&#x0005b;51&#x0005d;</xref>. As shown by Sakata et al., ASM also contributes to increased secretion of inflammatory cytokines in a murine model of experimental colitis <xref ref-type="bibr" rid="pone.0007197-Sakata1">&#x0005b;8&#x0005d;</xref>. Alteration of membrane fluidity by ceramide has also been shown to affect permeability of IEC <xref ref-type="bibr" rid="pone.0007197-Bock1">&#x0005b;52&#x0005d;</xref> and the function of diverse ion channels <xref ref-type="bibr" rid="pone.0007197-Lang1">&#x0005b;53&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007197-Bock2">&#x0005b;54&#x0005d;</xref>, which may also contribute to extensive loss of fluids and increase of IEC apoptosis in IBD. All of the effects mentioned above may be prevented by inhibition of ASM. Positive effects of imipramine on the clinical course of UC were shown by Esmaeili et al <xref ref-type="bibr" rid="pone.0007197-Esmaeili1">&#x0005b;55&#x0005d;</xref>. In view of our results, part of these effects are possibly explained by reduced production of MMP-1.</p><p>To address the question of PC administration, which has been reported to be protective in ulcerative colitis <xref ref-type="bibr" rid="pone.0007197-Fabia1">&#x0005b;5&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0007197-Stremmel1">&#x0005b;7&#x0005d;</xref>, we also compared levels of PC and its degradation product LPC. We did not find direct evidence for a deficiency of PC in intestinal epithelial cells but concentrations of LPC were much lower in inflamed colonic epithelium. This decrease is suggestive of a regulatory response of the mucosa to reduce inflammation, by reduction of inflammatory cytokines like IL-1&#x003b2; <xref ref-type="bibr" rid="pone.0007197-LiuWu1">&#x0005b;56&#x0005d;</xref> and less recruitment of monocytes and T cells <xref ref-type="bibr" rid="pone.0007197-Olofsson1">&#x0005b;19&#x0005d;</xref>. Therefore, the decrease of LPC most likely represents a mechanism of the intestinal mucosa for resolution of inflammation.</p><p>In summary, our data demonstrate increased levels of ceramide in experimental colitis. The results indicate a role of ceramide for the pathogenesis of IBD by regulation of MMP-1 expression. Pharmacologic inhibition of ASM by imipramine completely abrogates the induction of MMP-1 upon TNF or IL-1&#x003b2;. Therefore, inhibition of ASM may be a possible treatment strategy for intestinal inflammation, in particular ulcerative colitis.</p></sec></body><back><ref-list><title>References</title><ref id="pone.0007197-Schtze1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sch&#x000fc;tze</surname><given-names>S</given-names></name><name><surname>Machleidt</surname><given-names>T</given-names></name><name><surname>Kr&#x000f6;nke</surname><given-names>M</given-names></name></person-group><year>1994</year><article-title>The role of diacylglycerol and ceramide in tumor necrosis factor and interleukin-1 signal transduction.</article-title><source>J Leukoc Biol</source><volume>56</volume><fpage>533</fpage><lpage>541</lpage><pub-id pub-id-type="pmid">7964160</pub-id></mixed-citation></ref><ref id="pone.0007197-Heller1"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heller</surname><given-names>RA</given-names></name><name><surname>Kr&#x000f6;nke</surname><given-names>M</given-names></name></person-group><year>1994</year><article-title>Tumor necrosis factor receptor-mediated signalling pathways.</article-title><source>J Cell Biol</source><volume>126</volume><fpage>5</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">8027185</pub-id></mixed-citation></ref><ref id="pone.0007197-Hannun1"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hannun</surname><given-names>YA</given-names></name><name><surname>Obeid</surname><given-names>LM</given-names></name></person-group><year>2008</year><article-title>Principles of bioactive lipid signalling: lessons from sphingolipids.</article-title><source>Nat Rev Mol Cell Biol</source><volume>9</volume><fpage>139</fpage><lpage>150</lpage><pub-id pub-id-type="pmid">18216770</pub-id></mixed-citation></ref><ref id="pone.0007197-Wymann1"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wymann</surname><given-names>MP</given-names></name><name><surname>Schneiter</surname><given-names>R</given-names></name></person-group><year>2008</year><article-title>Lipid signalling in disease.</article-title><source>Nat Rev Mol Cell Biol</source><volume>9</volume><fpage>162</fpage><lpage>176</lpage><pub-id pub-id-type="pmid">18216772</pub-id></mixed-citation></ref><ref id="pone.0007197-Fabia1"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fabia</surname><given-names>R</given-names></name><name><surname>Ar'Rajab</surname><given-names>A</given-names></name><name><surname>Will&#x000e9;n</surname><given-names>R</given-names></name><name><surname>Andersson</surname><given-names>R</given-names></name><name><surname>Ahr&#x000e9;n</surname><given-names>B</given-names></name><etal/></person-group><year>1992</year><article-title>Effects of phosphatidylcholine and phosphatidylinositol on acetic-acid-induced colitis in the rat.</article-title><source>Digestion</source><volume>53</volume><fpage>35</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">1289171</pub-id></mixed-citation></ref><ref id="pone.0007197-Mourelle1"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mourelle</surname><given-names>M</given-names></name><name><surname>Guarner</surname><given-names>F</given-names></name><name><surname>Malagelada</surname><given-names>JR</given-names></name></person-group><year>1996</year><article-title>Polyunsaturated phosphatidylcholine prevents stricture formation in a rat model of colitis.</article-title><source>Gastroenterology</source><volume>110</volume><fpage>1093</fpage><lpage>1097</lpage><pub-id pub-id-type="pmid">8612998</pub-id></mixed-citation></ref><ref id="pone.0007197-Stremmel1"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stremmel</surname><given-names>W</given-names></name><name><surname>Merle</surname><given-names>U</given-names></name><name><surname>Zahn</surname><given-names>A</given-names></name><name><surname>Autschbach</surname><given-names>F</given-names></name><name><surname>Hinz</surname><given-names>U</given-names></name><etal/></person-group><year>2005</year><article-title>Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis.</article-title><source>Gut</source><volume>54</volume><fpage>966</fpage><lpage>971</lpage><pub-id pub-id-type="pmid">15951544</pub-id></mixed-citation></ref><ref id="pone.0007197-Sakata1"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakata</surname><given-names>A</given-names></name><name><surname>Ochiai</surname><given-names>T</given-names></name><name><surname>Shimeno</surname><given-names>H</given-names></name><name><surname>Hikishima</surname><given-names>S</given-names></name><name><surname>Yokomatsu</surname><given-names>T</given-names></name><etal/></person-group><year>2007</year><article-title>Acid sphingomyelinase inhibition suppresses lipopolysaccharide-mediated release of inflammatory cytokines from macrophages and protects against disease pathology in dextran sulphate sodium-induced colitis in mice.</article-title><source>Immunology</source><volume>122</volume><fpage>54</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">17451462</pub-id></mixed-citation></ref><ref id="pone.0007197-Smith1"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>EL</given-names></name><name><surname>Schuchman</surname><given-names>EH</given-names></name></person-group><year>2008</year><article-title>The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases.</article-title><source>FASEB J</source><volume>22</volume><fpage>3419</fpage><lpage>3431</lpage><pub-id pub-id-type="pmid">18567738</pub-id></mixed-citation></ref><ref id="pone.0007197-Gulbins1"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gulbins</surname><given-names>E</given-names></name></person-group><year>2003</year><article-title>Regulation of death receptor signalling and apoptosis by ceramide.</article-title><source>Pharmacol Res</source><volume>47</volume><fpage>393</fpage><lpage>399</lpage><pub-id pub-id-type="pmid">12676513</pub-id></mixed-citation></ref><ref id="pone.0007197-Ballou1"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ballou</surname><given-names>LR</given-names></name><name><surname>Laulederkind</surname><given-names>SJ</given-names></name><name><surname>Rosloniec</surname><given-names>EF</given-names></name><name><surname>Raghow</surname><given-names>R</given-names></name></person-group><year>1996</year><article-title>Ceramide signalling and the immune response.</article-title><source>Biochim Biophys Acta</source><volume>1301</volume><fpage>273</fpage><lpage>287</lpage><pub-id pub-id-type="pmid">8664339</pub-id></mixed-citation></ref><ref id="pone.0007197-Kolesnick1"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolesnick</surname><given-names>RN</given-names></name><name><surname>Haimovitz-Friedman</surname><given-names>A</given-names></name><name><surname>Fuks</surname><given-names>Z</given-names></name></person-group><year>1994</year><article-title>The sphingomyelin signal transduction pathway mediates apoptosis for tumor necrosis factor, Fas, and ionizing radiation.</article-title><source>Biochem Cell Biol</source><volume>72</volume><fpage>471</fpage><lpage>474</lpage><pub-id pub-id-type="pmid">7544586</pub-id></mixed-citation></ref><ref id="pone.0007197-Gulbins2"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gulbins</surname><given-names>E</given-names></name><name><surname>Kolesnick</surname><given-names>R</given-names></name></person-group><year>2003</year><article-title>Raft ceramide in molecular medicine.</article-title><source>Oncogene</source><volume>22</volume><fpage>7070</fpage><lpage>7077</lpage><pub-id pub-id-type="pmid">14557812</pub-id></mixed-citation></ref><ref id="pone.0007197-Duan1"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duan</surname><given-names>RD</given-names></name></person-group><year>2006</year><article-title>Alkaline sphingomyelinase: an old enzyme with novel implications.</article-title><source>Biochim Biophys Acta</source><volume>1761</volume><fpage>281</fpage><lpage>291</lpage><pub-id pub-id-type="pmid">16631405</pub-id></mixed-citation></ref><ref id="pone.0007197-Sakata2"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakata</surname><given-names>A</given-names></name><name><surname>Yasuda</surname><given-names>K</given-names></name><name><surname>Ochiai</surname><given-names>T</given-names></name><name><surname>Shimeno</surname><given-names>H</given-names></name><name><surname>Hikishima</surname><given-names>S</given-names></name><etal/></person-group><year>2007</year><article-title>Inhibition of lipopolysaccharide-induced release of interleukin-8 from intestinal epithelial cells by SMA, a novel inhibitor of sphingomyelinase and its therapeutic effect on dextran sulphate sodium-induced colitis in mice.</article-title><source>Cell Immunol</source><volume>245</volume><fpage>24</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">17466962</pub-id></mixed-citation></ref><ref id="pone.0007197-Ehehalt1"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehehalt</surname><given-names>R</given-names></name><name><surname>Krautter</surname><given-names>M</given-names></name><name><surname>Zorn</surname><given-names>M</given-names></name><name><surname>Sparla</surname><given-names>R</given-names></name><name><surname>Fullekrug</surname><given-names>J</given-names></name><etal/></person-group><year>2008</year><article-title>Increased basolateral sorting of carcinoembryonic antigen in a polarized colon carcinoma cell line after cholesterol depletion-Implications for treatment of inflammatory bowel disease.</article-title><source>World J Gastroenterol</source><volume>14</volume><fpage>1528</fpage><lpage>1533</lpage><pub-id pub-id-type="pmid">18330942</pub-id></mixed-citation></ref><ref id="pone.0007197-Treede1"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Treede</surname><given-names>I</given-names></name><name><surname>Braun</surname><given-names>A</given-names></name><name><surname>Sparla</surname><given-names>R</given-names></name><name><surname>K&#x000fc;hnel</surname><given-names>M</given-names></name><name><surname>Giese</surname><given-names>T</given-names></name><etal/></person-group><year>2007</year><article-title>Anti-inflammatory effects of phosphatidylcholine.</article-title><source>J Biol Chem</source><volume>282</volume><fpage>27155</fpage><lpage>27164</lpage><pub-id pub-id-type="pmid">17636253</pub-id></mixed-citation></ref><ref id="pone.0007197-McKean1"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKean</surname><given-names>ML</given-names></name><name><surname>Smith</surname><given-names>JB</given-names></name><name><surname>Silver</surname><given-names>MJ</given-names></name></person-group><year>1981</year><article-title>Formation of lysophosphatidylcholine by human platelets in response to thrombin. Support for the phospholipase A2 pathway for the liberation of arachidonic acid.</article-title><source>J Biol Chem</source><volume>256</volume><fpage>1522</fpage><lpage>1524</lpage><pub-id pub-id-type="pmid">7462211</pub-id></mixed-citation></ref><ref id="pone.0007197-Olofsson1"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olofsson</surname><given-names>KE</given-names></name><name><surname>Andersson</surname><given-names>L</given-names></name><name><surname>Nilsson</surname><given-names>J</given-names></name><name><surname>Bj&#x000f6;rkbacka</surname><given-names>H</given-names></name></person-group><year>2008</year><article-title>Nanomolar concentrations of lysophosphatidylcholine recruit monocytes and induce pro-inflammatory cytokine production in macrophages.</article-title><source>Biochem Biophys Res Commun</source><volume>370</volume><fpage>348</fpage><lpage>352</lpage><pub-id pub-id-type="pmid">18371300</pub-id></mixed-citation></ref><ref id="pone.0007197-Maskrey1"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maskrey</surname><given-names>BH</given-names></name><name><surname>Berm&#x000fa;dez-Fajardo</surname><given-names>A</given-names></name><name><surname>Morgan</surname><given-names>AH</given-names></name><name><surname>Stewart-Jones</surname><given-names>E</given-names></name><name><surname>Dioszeghy</surname><given-names>V</given-names></name><etal/></person-group><year>2007</year><article-title>Activated platelets and monocytes generate four hydroxyphosphatidylethanolamines via lipoxygenase.</article-title><source>J Biol Chem</source><volume>282</volume><fpage>20151</fpage><lpage>20163</lpage><pub-id pub-id-type="pmid">17519227</pub-id></mixed-citation></ref><ref id="pone.0007197-Wang1"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>YD</given-names></name><name><surname>Mao</surname><given-names>JW</given-names></name></person-group><year>2007</year><article-title>Expression of matrix metalloproteinase-1 and tumor necrosis factor-alpha in ulcerative colitis.</article-title><source>World J Gastroenterol</source><volume>13</volume><fpage>5926</fpage><lpage>5932</lpage><pub-id pub-id-type="pmid">17990358</pub-id></mixed-citation></ref><ref id="pone.0007197-Meijer1"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meijer</surname><given-names>MJ</given-names></name><name><surname>Mieremet-Ooms</surname><given-names>MA</given-names></name><name><surname>van Hogezand</surname><given-names>RA</given-names></name><name><surname>Lamers</surname><given-names>CB</given-names></name><name><surname>Hommes</surname><given-names>DW</given-names></name><etal/></person-group><year>2007</year><article-title>Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel disease.</article-title><source>World J Gastroenterol</source><volume>13</volume><fpage>2960</fpage><lpage>2966</lpage><pub-id pub-id-type="pmid">17589947</pub-id></mixed-citation></ref><ref id="pone.0007197-Westermarck1"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westermarck</surname><given-names>J</given-names></name><name><surname>K&#x000e4;h&#x000e4;ri</surname><given-names>VM</given-names></name></person-group><year>1999</year><article-title>Regulation of matrix metalloproteinase expression in tumor invasion.</article-title><source>FASEB J</source><volume>13</volume><fpage>781</fpage><lpage>792</lpage><pub-id pub-id-type="pmid">10224222</pub-id></mixed-citation></ref><ref id="pone.0007197-Sengupta1"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sengupta</surname><given-names>N</given-names></name><name><surname>MacDonald</surname><given-names>TT</given-names></name></person-group><year>2007</year><article-title>The role of matrix metalloproteinases in stromal/epithelial interactions in the gut.</article-title><source>Physiology (Bethesda)</source><volume>22</volume><fpage>401</fpage><lpage>409</lpage><pub-id pub-id-type="pmid">18073413</pub-id></mixed-citation></ref><ref id="pone.0007197-Naito1"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naito</surname><given-names>Y</given-names></name><name><surname>Yoshikawa</surname><given-names>T</given-names></name></person-group><year>2005</year><article-title>Role of matrix metalloproteinases in inflammatory bowel diseases.</article-title><source>Molecular Aspects of Medicine</source><volume>26</volume><fpage>379</fpage><lpage>390</lpage><pub-id pub-id-type="pmid">16112187</pub-id></mixed-citation></ref><ref id="pone.0007197-WojtowiczPraga1"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wojtowicz-Praga</surname><given-names>SM</given-names></name><name><surname>Dickson</surname><given-names>RB</given-names></name><name><surname>Hawkins</surname><given-names>MJ</given-names></name></person-group><year>1997</year><article-title>Matrix metalloproteinase inhibitors.</article-title><source>Invest New Drugs</source><volume>15</volume><fpage>61</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">9195290</pub-id></mixed-citation></ref><ref id="pone.0007197-Baugh1"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baugh</surname><given-names>MD</given-names></name><name><surname>Perry</surname><given-names>MJ</given-names></name><name><surname>Hollander</surname><given-names>AP</given-names></name><name><surname>Davies</surname><given-names>DR</given-names></name><name><surname>Cross</surname><given-names>SS</given-names></name><etal/></person-group><year>1999</year><article-title>Matrix metalloproteinase level are elevated in inflammatory bowel disease.</article-title><source>Gastroenterology</source><volume>177</volume><fpage>814</fpage><lpage>822</lpage><pub-id pub-id-type="pmid">10500063</pub-id></mixed-citation></ref><ref id="pone.0007197-Heuschkel1"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heuschkel</surname><given-names>RB</given-names></name><name><surname>MacDonald</surname><given-names>TT</given-names></name><name><surname>Monteleone</surname><given-names>G</given-names></name><name><surname>Bajaj-Elliott</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>JA</given-names></name><etal/></person-group><year>2000</year><article-title>Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesion of children with inflammatory bowel disease.</article-title><source>Gut</source><volume>47</volume><fpage>57</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">10861265</pub-id></mixed-citation></ref><ref id="pone.0007197-Mackay1"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackay</surname><given-names>AR</given-names></name><name><surname>Ballin</surname><given-names>M</given-names></name><name><surname>Pelina</surname><given-names>MD</given-names></name><name><surname>Farina</surname><given-names>AR</given-names></name><name><surname>Nason</surname><given-names>AM</given-names></name><etal/></person-group><year>1992</year><article-title>Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.</article-title><source>Invasion Metastasis</source><volume>12</volume><fpage>168</fpage><lpage>184</lpage><pub-id pub-id-type="pmid">1284126</pub-id></mixed-citation></ref><ref id="pone.0007197-Lafuma1"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lafuma</surname><given-names>C</given-names></name><name><surname>El Nabout</surname><given-names>RA</given-names></name><name><surname>Crechet</surname><given-names>F</given-names></name><name><surname>Hovnanian</surname><given-names>A</given-names></name><name><surname>Martin</surname><given-names>M</given-names></name></person-group><year>1994</year><article-title>Expression of 72-kDa gelatinase (MMP-2), collagenase (MMP-1), and tissue metalloproteinase inhibitor (TIMP) in primary pig skin fibroblast cultures derived from radiation-induced skin fibrosis.</article-title><source>J Invest Dermatol</source><volume>102</volume><fpage>945</fpage><lpage>950</lpage><pub-id pub-id-type="pmid">8006459</pub-id></mixed-citation></ref><ref id="pone.0007197-Wlaschek1"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wlaschek</surname><given-names>M</given-names></name><name><surname>Heinen</surname><given-names>G</given-names></name><name><surname>Poswig</surname><given-names>A</given-names></name><name><surname>Schwarz</surname><given-names>A</given-names></name><name><surname>Krieg</surname><given-names>T</given-names></name><etal/></person-group><year>1994</year><article-title>UVA-induced autocrine stimulation of fibroblast-derived collagenase/MMP-1 by interrelated loops of interleukin-1 and interleukin-6.</article-title><source>Photochem Photobiol</source><volume>59</volume><fpage>550</fpage><lpage>556</lpage><pub-id pub-id-type="pmid">8041811</pub-id></mixed-citation></ref><ref id="pone.0007197-Reunanen1"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reunanen</surname><given-names>N</given-names></name><name><surname>Westermarck</surname><given-names>J</given-names></name><name><surname>H&#x000e4;kkinen</surname><given-names>L</given-names></name><name><surname>Holmstr&#x000f6;m</surname><given-names>TH</given-names></name><name><surname>Elo</surname><given-names>I</given-names></name><etal/></person-group><year>1998</year><article-title>Enhancement of fibroblast collagenase (matrix metalloproteinase-1) gene expression by ceramide is mediated by extracellular signal-regulated and stress-activated protein kinase pathways.</article-title><source>J Biol Chem</source><volume>273</volume><fpage>5137</fpage><lpage>5145</lpage><pub-id pub-id-type="pmid">9478967</pub-id></mixed-citation></ref><ref id="pone.0007197-Bu1"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bu</surname><given-names>S</given-names></name><name><surname>Yamanaka</surname><given-names>M</given-names></name><name><surname>Pei</surname><given-names>H</given-names></name><name><surname>Bielawska</surname><given-names>A</given-names></name><name><surname>Bielawska</surname><given-names>J</given-names></name><etal/></person-group><year>2006</year><article-title>Dihydrosphingosine 1-phosphate stimulates MMP1 gene expression via activation of ERK1/2-Ets1 pathway in human fibroblasts.</article-title><source>FASEB J</source><volume>20</volume><fpage>184</fpage><lpage>186</lpage><pub-id pub-id-type="pmid">16278291</pub-id></mixed-citation></ref><ref id="pone.0007197-Leeb1"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leeb</surname><given-names>SN</given-names></name><name><surname>Vogl</surname><given-names>D</given-names></name><name><surname>Falk</surname><given-names>W</given-names></name><name><surname>Sch&#x000f6;lmerich</surname><given-names>J</given-names></name><name><surname>Rogler</surname><given-names>G</given-names></name><etal/></person-group><year>2002</year><article-title>Regulation of migration of human colonic myofibroblasts.</article-title><source>Growth Factors</source><volume>20</volume><fpage>81</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">12148566</pub-id></mixed-citation></ref><ref id="pone.0007197-Brenmoehl1"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brenmoehl</surname><given-names>J</given-names></name><name><surname>Falk</surname><given-names>W</given-names></name><name><surname>G&#x000f6;ke</surname><given-names>M</given-names></name><name><surname>Sch&#x000f6;lmerich</surname><given-names>J</given-names></name><name><surname>Rogler</surname><given-names>G</given-names></name></person-group><year>2008</year><article-title>Inflammation modulates fibronectin isoform expression in colonic lamina propria fibroblasts (CLPF).</article-title><source>Int J Colorectal Dis</source><volume>23</volume><fpage>947</fpage><lpage>955</lpage><pub-id pub-id-type="pmid">18633626</pub-id></mixed-citation></ref><ref id="pone.0007197-Obermeier1"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obermeier</surname><given-names>F</given-names></name><name><surname>Kojouharoff</surname><given-names>G</given-names></name><name><surname>Hans</surname><given-names>W</given-names></name><name><surname>Sch&#x000f6;lmerich</surname><given-names>J</given-names></name><name><surname>Gross</surname><given-names>V</given-names></name><etal/></person-group><year>1999</year><article-title>Interferon-gamma (IFN-gamma) - and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice.</article-title><source>Clin Exp Immunol</source><volume>116</volume><fpage>238</fpage><lpage>245</lpage><pub-id pub-id-type="pmid">10337013</pub-id></mixed-citation></ref><ref id="pone.0007197-Neurath1"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neurath</surname><given-names>MF</given-names></name><name><surname>Weigmann</surname><given-names>B</given-names></name><name><surname>Finotto</surname><given-names>S</given-names></name><name><surname>Glickmann</surname><given-names>J</given-names></name><name><surname>Nieuwenhuis</surname><given-names>E</given-names></name><etal/></person-group><year>2002</year><article-title>The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease.</article-title><source>J Exp Med</source><volume>195</volume><fpage>1129</fpage><lpage>1143</lpage><pub-id pub-id-type="pmid">11994418</pub-id></mixed-citation></ref><ref id="pone.0007197-Mudter1"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mudter</surname><given-names>J</given-names></name><name><surname>Wirtz</surname><given-names>S</given-names></name><name><surname>Galle</surname><given-names>PR</given-names></name><name><surname>Neurath</surname><given-names>MF</given-names></name></person-group><year>2002</year><article-title>A new model of chronic colitis in SCID mice induced by adoptive transfer of CD62L&#x0002b; CD4&#x0002b; T cells: insights into the regulatory role of interleukin-6 on apoptosis.</article-title><source>Pathobiology</source><volume>70</volume><fpage>170</fpage><lpage>176</lpage><pub-id pub-id-type="pmid">12571422</pub-id></mixed-citation></ref><ref id="pone.0007197-Steidler1"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steidler</surname><given-names>L</given-names></name><name><surname>Hans</surname><given-names>W</given-names></name><name><surname>Schotte</surname><given-names>L</given-names></name><name><surname>Neirynck</surname><given-names>S</given-names></name><name><surname>Obermeier</surname><given-names>F</given-names></name><etal/></person-group><year>2000</year><article-title>Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.</article-title><source>Science</source><volume>289</volume><fpage>1352</fpage><lpage>1355</lpage><pub-id pub-id-type="pmid">10958782</pub-id></mixed-citation></ref><ref id="pone.0007197-Langmann1"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langmann</surname><given-names>T</given-names></name><name><surname>Moehle</surname><given-names>C</given-names></name><name><surname>Mauerer</surname><given-names>R</given-names></name><name><surname>Scharl</surname><given-names>M</given-names></name><name><surname>Liebisch</surname><given-names>G</given-names></name><etal/></person-group><year>2004</year><article-title>Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes.</article-title><source>Gastroenterology</source><volume>127</volume><fpage>26</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">15236169</pub-id></mixed-citation></ref><ref id="pone.0007197-Daig1"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daig</surname><given-names>R</given-names></name><name><surname>Rogler</surname><given-names>G</given-names></name><name><surname>Aschenbrenner</surname><given-names>E</given-names></name><name><surname>Vogl</surname><given-names>D</given-names></name><name><surname>Falk</surname><given-names>W</given-names></name><etal/></person-group><year>2000</year><article-title>Human intestinal epithelial cells secrete interleukin-1 receptor antagonist and interleukin-8 but not interleukin-1 or interleukin-6.</article-title><source>Gut</source><volume>46</volume><fpage>350</fpage><lpage>358</lpage><pub-id pub-id-type="pmid">10673296</pub-id></mixed-citation></ref><ref id="pone.0007197-Liebisch1"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liebisch</surname><given-names>G</given-names></name><name><surname>Lieser</surname><given-names>B</given-names></name><name><surname>Rathenberg</surname><given-names>J</given-names></name><name><surname>Drobnik</surname><given-names>W</given-names></name><name><surname>Schmitz</surname><given-names>G</given-names></name></person-group><year>2004</year><article-title>High-throughput quantification of phosphatidylcholine and sphingomyelin by electrospray ionization tandem mass spectrometry coupled with isotope correction algorithm. Biochim Biophys Acta 1686: 108-117.</article-title><source>Erratum in: Biochim Biophys Acta 2005</source><volume>1734</volume><fpage>86</fpage><lpage>89</lpage></mixed-citation></ref><ref id="pone.0007197-Wiesener1"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiesener</surname><given-names>P</given-names></name><name><surname>Leidl</surname><given-names>K</given-names></name><name><surname>Boettcher</surname><given-names>A</given-names></name><name><surname>Schmitz</surname><given-names>G</given-names></name><name><surname>Liebisch</surname><given-names>G</given-names></name></person-group><year>2009</year><article-title>Lipid profiling of FPLC-separated lipoprotein fraction by electrospray ionization tandem mass spectrometry.</article-title><source>J Lipid Res</source><volume>50</volume><fpage>574</fpage><lpage>585</lpage><pub-id pub-id-type="pmid">18832345</pub-id></mixed-citation></ref><ref id="pone.0007197-Farr1"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farr</surname><given-names>A</given-names></name><name><surname>Nelson</surname><given-names>A</given-names></name><name><surname>Truex</surname><given-names>J</given-names></name><name><surname>Hosier</surname><given-names>S</given-names></name></person-group><year>1991</year><article-title>Epithelial heterogeneity in the murine thymus: A cell surface glycoprotein expressed by subcapsular and medullary epithelium.</article-title><source>J Histochem Cytochem</source><volume>39</volume><fpage>645</fpage><lpage>653</lpage><pub-id pub-id-type="pmid">2016514</pub-id></mixed-citation></ref><ref id="pone.0007197-Albouz1"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albouz</surname><given-names>S</given-names></name><name><surname>Hauw</surname><given-names>JJ</given-names></name><name><surname>Berwald-Netter</surname><given-names>Y</given-names></name><name><surname>Boutry</surname><given-names>JM</given-names></name><name><surname>Bourdon</surname><given-names>R</given-names></name><etal/></person-group><year>1981</year><article-title>Tricyclic antidepressants induce sphingomyelinase deficiency in fibroblast and neuroblastoma cell cultures.</article-title><source>Biomedicine</source><volume>35</volume><fpage>218</fpage><lpage>220</lpage><pub-id pub-id-type="pmid">6285997</pub-id></mixed-citation></ref><ref id="pone.0007197-Hurwitz1"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hurwitz</surname><given-names>R</given-names></name><name><surname>Ferlinz</surname><given-names>K</given-names></name><name><surname>Sandhoff</surname><given-names>K</given-names></name></person-group><year>1994</year><article-title>The tricyclic antidepressant desipramine causes proteolytic degradation of lysosomal sphingomyelinase in human fibroblasts.</article-title><source>Biol Chem Hoppe Seyler</source><volume>375</volume><fpage>447</fpage><lpage>450</lpage><pub-id pub-id-type="pmid">7945993</pub-id></mixed-citation></ref><ref id="pone.0007197-Jensen1"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>JM</given-names></name><name><surname>Sch&#x000fc;tze</surname><given-names>S</given-names></name><name><surname>F&#x000f6;rl</surname><given-names>M</given-names></name><name><surname>Kr&#x000f6;nke</surname><given-names>M</given-names></name><name><surname>Proksch</surname><given-names>E</given-names></name></person-group><year>1999</year><article-title>Roles for tumor necrosis factor receptor p55 and sphingomyelinase in repairing the cutaneous permeability barrier.</article-title><source>J Clin Invest</source><volume>104</volume><fpage>1761</fpage><lpage>1770</lpage><pub-id pub-id-type="pmid">10606630</pub-id></mixed-citation></ref><ref id="pone.0007197-Bauer1"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname><given-names>J</given-names></name><name><surname>Huy</surname><given-names>C</given-names></name><name><surname>Brenmoehl</surname><given-names>J</given-names></name><name><surname>Obermeier</surname><given-names>F</given-names></name><name><surname>Bock</surname><given-names>J</given-names></name></person-group><year>2009</year><article-title>Matrix metalloproteinase-1 expression induced by IL-1&#x003b2; requires acid sphingomyelinase.</article-title><source>FEBS Letters</source><volume>585</volume><fpage>915</fpage><lpage>920</lpage><pub-id pub-id-type="pmid">19302792</pub-id></mixed-citation></ref><ref id="pone.0007197-Schtze2"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sch&#x000fc;tze</surname><given-names>S</given-names></name><name><surname>Potthoff</surname><given-names>K</given-names></name><name><surname>Machtleidt</surname><given-names>T</given-names></name><name><surname>Berkovic</surname><given-names>D</given-names></name><name><surname>Wiegmann</surname><given-names>K</given-names></name><etal/></person-group><year>1992</year><article-title>TNF achtivates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced &#x0201c;acidic&#x0201d; sphingomyelin breakdown.</article-title><source>Cell</source><volume>71</volume><fpage>765</fpage><lpage>776</lpage><pub-id pub-id-type="pmid">1330325</pub-id></mixed-citation></ref><ref id="pone.0007197-Hofmeister1"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hofmeister</surname><given-names>R</given-names></name><name><surname>Wiegmann</surname><given-names>K</given-names></name><name><surname>Korherr</surname><given-names>C</given-names></name><name><surname>Bernardo</surname><given-names>K</given-names></name><name><surname>Kr&#x000f6;nke</surname><given-names>M</given-names></name><etal/></person-group><year>1997</year><article-title>Activation of acid sphingomyelinase by interleukin-1 (IL-1) requires the IL-1 receptor accessory protein.</article-title><source>J Biol Chem</source><volume>272</volume><fpage>27730</fpage><lpage>27736</lpage><pub-id pub-id-type="pmid">9346915</pub-id></mixed-citation></ref><ref id="pone.0007197-Teichgrber1"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teichgr&#x000e4;ber</surname><given-names>V</given-names></name><name><surname>Ulrich</surname><given-names>M</given-names></name><name><surname>Endlich</surname><given-names>N</given-names></name><name><surname>Riethm&#x000fc;ller</surname><given-names>J</given-names></name><name><surname>Wilker</surname><given-names>B</given-names></name><etal/></person-group><year>2008</year><article-title>Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis.</article-title><source>Nat Med</source><volume>14</volume><fpage>382</fpage><lpage>391</lpage><pub-id pub-id-type="pmid">18376404</pub-id></mixed-citation></ref><ref id="pone.0007197-Bock1"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bock</surname><given-names>J</given-names></name><name><surname>Liebisch</surname><given-names>G</given-names></name><name><surname>Schweimer</surname><given-names>J</given-names></name><name><surname>Schmitz</surname><given-names>G</given-names></name><name><surname>Rogler</surname><given-names>G</given-names></name></person-group><year>2007</year><article-title>Exogenous sphingomyelinase causes impaired intestinal epithelial barrier function.</article-title><source>World J Gastroenterology</source><volume>13</volume><fpage>5217</fpage><lpage>5225</lpage></mixed-citation></ref><ref id="pone.0007197-Lang1"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lang</surname><given-names>F</given-names></name><name><surname>Huber</surname><given-names>SM</given-names></name><name><surname>Szabo</surname><given-names>I</given-names></name><name><surname>Gulbins</surname><given-names>E</given-names></name></person-group><year>2007</year><article-title>Plasma membrane ion channels in suicidal cell death.</article-title><source>Arch Biochem Biophys</source><volume>462</volume><fpage>189</fpage><lpage>194</lpage><pub-id pub-id-type="pmid">17316548</pub-id></mixed-citation></ref><ref id="pone.0007197-Bock2"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bock</surname><given-names>J</given-names></name><name><surname>Szab&#x000f3;</surname><given-names>I</given-names></name><name><surname>Gamper</surname><given-names>N</given-names></name><name><surname>Adams</surname><given-names>C</given-names></name><name><surname>Gulbins</surname><given-names>E</given-names></name></person-group><year>2003</year><article-title>Ceramide inhibits the potassium channel Kv1.3 by the formation of membrane platforms.</article-title><source>Biochem Biophys Res Commun</source><volume>305</volume><fpage>890</fpage><lpage>897</lpage><pub-id pub-id-type="pmid">12767914</pub-id></mixed-citation></ref><ref id="pone.0007197-Esmaeili1"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esmaeili</surname><given-names>A</given-names></name><name><surname>Masjedi</surname><given-names>M</given-names></name><name><surname>Ani</surname><given-names>A</given-names></name><name><surname>Farajzadegan</surname><given-names>Z</given-names></name><name><surname>Behbahani</surname><given-names>A</given-names></name><etal/></person-group><year>2008</year><article-title>New insights of anti-depressant therapy in the management of ulcerative colitis (UC).</article-title><source>Gastroenterology</source><volume>134</volume><fpage>A</fpage><lpage>100 &#x0005b;#705&#x0005d;</lpage></mixed-citation></ref><ref id="pone.0007197-LiuWu1"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu-Wu</surname><given-names>Y</given-names></name><name><surname>Hurt-Camejo</surname><given-names>E</given-names></name><name><surname>Wiklund</surname><given-names>O</given-names></name></person-group><year>1998</year><article-title>Lysophosphatidylcholine induces the production of IL-1beta by human monocytes.</article-title><source>Atherosclerosis</source><volume>137</volume><fpage>351</fpage><lpage>357</lpage><pub-id pub-id-type="pmid">9622278</pub-id></mixed-citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>This work was supported by the German Research Foundation DFG BO 2529/2-1 to JB and OB 135/10-1 to FO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group></back></article>